(RLJ) RLJ Lodging Trust - Ratings and Ratios
Hotels, Lodging, REIT, Urban, Premium-Brand
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 26.3% |
| Value at Risk 5%th | 40.2% |
| Relative Tail Risk | -7.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.42 |
| Alpha | -30.32 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.423 |
| Beta | 1.202 |
| Beta Downside | 1.236 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.93% |
| Mean DD | 20.24% |
| Median DD | 20.23% |
Description: RLJ RLJ Lodging Trust November 17, 2025
RLJ Lodging Trust (NYSE:RLJ) is a self-advised REIT that owns 94 premium-branded, rooms-focused hotels situated in high-margin, urban cores across the United States. The portfolio is deliberately diversified across major metropolitan markets, allowing exposure to a mix of business, leisure, and ancillary travel demand.
Key industry metrics that currently shape RLJ’s outlook include: (1) U.S. upscale hotel occupancy, which the STR report shows hovering around 71% in Q3 2024-approximately 4 percentage points above the five-year average, supporting higher RevPAR; (2) average daily rate (ADR) growth of roughly 6% YoY in the same period, driven by limited new supply in dense urban zones; and (3) interest-rate sensitivity, as REITs with sizable debt portfolios (RLJ’s leverage ratio was ~6.2× FY 2023) may see cost-of-capital pressure if the Federal Reserve maintains rates above 5%.
If you want a data-driven, side-by-side comparison of RLJ’s valuation multiples, occupancy trends, and peer performance, the ValueRay platform provides a concise dashboard that can help you test the robustness of your investment thesis.
RLJ Stock Overview
| Market Cap in USD | 1,136m |
| Sub-Industry | Hotel & Resort REITs |
| IPO / Inception | 2011-05-11 |
| Return 12m vs S&P 500 | -26.4% |
| Analyst Rating | 3.30 of 5 |
RLJ Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 7.98% |
| Yield on Cost 5y | 5.64% |
| Yield CAGR 5y | 88.03% |
| Payout Consistency | 91.9% |
| Payout Ratio | 9.3% |
RLJ Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | -9.38% |
| CAGR/Max DD Calmar Ratio | -0.21 |
| CAGR/Mean DD Pain Ratio | -0.46 |
| Current Volume | 1624.9k |
| Average Volume | 1524.4k |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (27.2m TTM) > 0 and > 6% of Revenue (6% = 81.1m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 26.96% (prev 15.94%; Δ 11.02pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 251.9m > Net Income 27.2m (YES >=105%, WARN >=100%) |
| Net Debt (-374.8m) to EBITDA (301.0m) ratio: -1.25 <= 3.0 (WARN <= 3.5) |
| Current Ratio 9.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (149.1m) change vs 12m ago -2.68% (target <= -2.0% for YES) |
| Gross Margin 26.79% (prev 28.27%; Δ -1.48pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 27.92% (prev 27.81%; Δ 0.11pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.06 (EBITDA TTM 301.0m / Interest Expense TTM 106.4m) >= 6 (WARN >= 3) |
Altman Z'' -0.59
| (A) 0.08 = (Total Current Assets 405.2m - Total Current Liabilities 40.9m) / Total Assets 4.79b |
| (B) -0.24 = Retained Earnings (Balance) -1.15b / Total Assets 4.79b |
| (C) 0.02 = EBIT TTM 113.1m / Avg Total Assets 4.84b |
| (D) -0.44 = Book Value of Equity -1.15b / Total Liabilities 2.59b |
| Total Rating: -0.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.25
| 1. Piotroski 3.0pt |
| 2. FCF Yield 8.13% |
| 3. FCF Margin 18.65% |
| 4. Debt/Equity 1.07 |
| 5. Debt/Ebitda -1.25 |
| 6. ROIC - WACC (= -1.27)% |
| 7. RoE 1.22% |
| 8. Rev. Trend 41.38% |
| 9. EPS Trend -50.91% |
What is the price of RLJ shares?
Over the past week, the price has changed by +1.21%, over one month by +6.06%, over three months by +4.44% and over the past year by -17.34%.
Is RLJ a buy, sell or hold?
- Strong Buy: 3
- Buy: 0
- Hold: 5
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the RLJ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 8.6 | 14.9% |
| Analysts Target Price | 8.6 | 14.9% |
| ValueRay Target Price | 8 | 6.3% |
RLJ Fundamental Data Overview November 15, 2025
P/E Trailing = 149.6
P/E Forward = 144.9275
P/S = 0.8407
P/B = 0.6216
P/EG = 1.41
Beta = 1.175
Revenue TTM = 1.35b USD
EBIT TTM = 113.1m USD
EBITDA TTM = 301.0m USD
Long Term Debt = 2.22b USD (from longTermDebt, last quarter)
Short Term Debt = 190.7m USD (from shortTermDebt, last fiscal year)
Debt = 2.34b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -374.8m USD (from netDebt column, last quarter)
Enterprise Value = 3.10b USD (1.14b + Debt 2.34b - CCE 374.8m)
Interest Coverage Ratio = 1.06 (Ebit TTM 113.1m / Interest Expense TTM 106.4m)
FCF Yield = 8.13% (FCF TTM 251.9m / Enterprise Value 3.10b)
FCF Margin = 18.65% (FCF TTM 251.9m / Revenue TTM 1.35b)
Net Margin = 2.01% (Net Income TTM 27.2m / Revenue TTM 1.35b)
Gross Margin = 26.79% ((Revenue TTM 1.35b - Cost of Revenue TTM 989.2m) / Revenue TTM)
Gross Margin QoQ = 24.25% (prev 30.43%)
Tobins Q-Ratio = 0.65 (Enterprise Value 3.10b / Total Assets 4.79b)
Interest Expense / Debt = 1.21% (Interest Expense 28.3m / Debt 2.34b)
Taxrate = -9.86% (negative due to tax credits) (341.0k / -3.46m)
NOPAT = 124.2m (EBIT 113.1m * (1 - -9.86%)) [negative tax rate / tax credits]
Current Ratio = 9.92 (Total Current Assets 405.2m / Total Current Liabilities 40.9m)
Debt / Equity = 1.07 (Debt 2.34b / totalStockholderEquity, last quarter 2.19b)
Debt / EBITDA = -1.25 (Net Debt -374.8m / EBITDA 301.0m)
Debt / FCF = -1.49 (Net Debt -374.8m / FCF TTM 251.9m)
Total Stockholder Equity = 2.24b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.57% (Net Income 27.2m / Total Assets 4.79b)
RoE = 1.22% (Net Income TTM 27.2m / Total Stockholder Equity 2.24b)
RoCE = 2.54% (EBIT 113.1m / Capital Employed (Equity 2.24b + L.T.Debt 2.22b))
RoIC = 3.04% (NOPAT 124.2m / Invested Capital 4.09b)
WACC = 4.31% (E(1.14b)/V(3.48b) * Re(10.45%) + D(2.34b)/V(3.48b) * Rd(1.21%) * (1-Tc(-0.10)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF Debug] Terminal Value 74.02% ; FCFE base≈260.4m ; Y1≈321.2m ; Y5≈548.0m
Fair Price DCF = 41.21 (DCF Value 6.23b / Shares Outstanding 151.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -50.91 | EPS CAGR: -77.84% | SUE: -2.02 | # QB: 0
Revenue Correlation: 41.38 | Revenue CAGR: 3.26% | SUE: 1.94 | # QB: 1
Additional Sources for RLJ Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle